ACQUISITION OF SCHIRM ACQUISITION OF SCHIRM DATE Replace pic/ - - PowerPoint PPT Presentation

acquisition of
SMART_READER_LITE
LIVE PREVIEW

ACQUISITION OF SCHIRM ACQUISITION OF SCHIRM DATE Replace pic/ - - PowerPoint PPT Presentation

ACQUISITION OF SCHIRM ACQUISITION OF SCHIRM DATE Replace pic/ use one of factory NOVEMBER 2017 30 October 2017 AGENDA 1. CONTEXT AND INVESTMENT SUMMARY 2. ABOUT SCHIRM 3. FINANCIAL INFORMATION Investment highlights 4.


slide-1
SLIDE 1

ACQUISITION OF SCHIRM

DATE

Replace pic/ use one of factory

ACQUISITION OF SCHIRM

NOVEMBER 2017

30 October 2017

slide-2
SLIDE 2

› Investment highlights

AGENDA 1. CONTEXT AND INVESTMENT SUMMARY 2. ABOUT SCHIRM

  • 3. FINANCIAL INFORMATION

4. OPPORTUNITIES

  • 5. INCORPORATION INTO AECI
slide-3
SLIDE 3

1 CONTEXT AND INVESTMENT SUMMARY

slide-4
SLIDE 4

3

CONTEXT: 1H17 RESULTS PRESENTATION

› Global mining activity gaining momentum

» Positive for Group’s Mining pillar » New contracts and increased market share » Footprint expanded » Good order book for mining chemicals

› No significant improvement in SA manufacturing sector anticipated to year-end However:

» Good opportunities in Water » Agriculture and Food businesses seasonal – stronger 2H historically » Rainfall patterns will affect agricultural sector performance

› Pursue further footprint and market expansion › Strong pipeline of acquisitions › Focus on working capital and capex management, and costs › Accelerate growth through Innovation projects, including AECI.GO

slide-5
SLIDE 5

STRATEGIC PILLARS

4

slide-6
SLIDE 6

INVESTMENT SUMMARY

5

Schirm is a contract manufacturer of agro and fine chemicals with a European and US footprint Largest provider of external agrochemical formulation services in Europe AECI’s first major acquisition in Europe Geographic diversification Earnings diversification Integrated

  • ffering across

synthesis, formulation and packaging Total production volume of 165 000tpa 4 synthesis units 55 formulation units 81 packaging units 800 permanent employees

slide-7
SLIDE 7

INVESTMENT CASE

6

Supply chain

  • pportunities

Market leader in provision of formulation services for agrochemicals in Europe Long-standing relationships with blue-chip customer base Substantial investment in capex over past two years to deliver growth Extension of Schirm’s manufacturing and distribution expertise Enhanced geographic and product diversity Seasonal benefits Currency diversification in earnings

slide-8
SLIDE 8

GEOGRAPHIC FOOTPRINT

7

5

Ennis (Texas, USA)

1 2 3 4 5

Wolfenbüttel Lübeck Schӧnebeck Baar-Ebenhausen

USA GERMANY

slide-9
SLIDE 9

2 ABOUT SCHIRM

slide-10
SLIDE 10

SCHIRM’S HISTORY: EXPANSION OF VALUE CHAIN AND FOOTPRINT

› Other milestones

» ’13: new extrusion facility, Wolfenbüttel » ’15: new blending and repacking facility, Baar-Ebenhausen » ’16: new fungicide formulation centre, Schӧnebeck » ’17: new synthesis capacity, Schӧnebeck » ’17: new Henkel plant, Wolfenbüttel

Schirm established

  • focus on pharma

repacking services Agrochemicals formulations Acquired by Lehnkering 2000: acquisition

  • f formulation

plant, Ennis Imperial acquires Lehnkering and all subsidiaries, incl. Schirm Agrochemicals packaging Acquired Schӧnebeck site 2002: first MPP synthesis plant in Schӧnebeck 2008: acquisition of Wolfenbüttel business

1957 1972 1975 1992 2000 - 2008 2011

9

slide-11
SLIDE 11

SCHIRM FOOTPRINT DETAILS

10

Baar-Ebenhausen Formulation units: 11 Packaging units: 22 Production volume: 11 000t Wolfenbüttel Formulation units: 6 Packaging units: 12 Production volume: 32 000t Ennis/Texas Formulation units: 26 Packaging units: 16 Distribution storage: 28 000m2 Production volume: 77 000t Schönebeck Synthesis units: 4 Formulation units: 7 Packaging units: 16 Production volume: 33 000t Lübeck Formulation units: 5 Packaging units: 15 Production volume: 12 000t

slide-12
SLIDE 12

VALUE CHAIN

COMPETITIVE ADVANTAGE AND ENHANCED FINANCIAL STABILITY - ENTIRE VALUE CHAIN

VALUE CHAIN

11

Synthesis Formulation Packaging

› Process engineering, scale-up and synthesis

  • f organic compounds

› Broad range of reaction types › Formulation of active ingredients › Wide range of technical capabilities › Packaging and labeling of liquid and solid products in all pack sizes › Services include hazardous substances 4 55 81

Description

  • No. of units

Production Volume (tpa)

Current: 2 400t Expanded: 5 400t – 6 400t 98 500t 63 100t

slide-13
SLIDE 13

REVENUE AND SERVICE SPLIT

12

BY END-MARKET APPLICATION

Agrochemicals 80% Fine chemicals 20%

BY PRODUCTION SERVICE

Synthesis 7% Formulation 53% Packaging 40%

slide-14
SLIDE 14

CUSTOMERS: LONG-STANDING RELATIONSHIPS

13

FOCUSED ON END MARKETS WITH ATTRACTIVE GROWTH RATES, SUPPORTED BY GLOBAL MEGATRENDS PRODUCT SPILT KEY PRODUCT CATE TEGORI ORIES ES (~ %) KEY CUSTOMERS

Revenue: €91m

Agrochemicals 80% Herbicides Fungicides Insecticides Other

50 25 10 15

Mid-term market growth (~ %) 3 4 2

slide-15
SLIDE 15

CUSTOMERS: LONG-STANDING RELATIONSHIPS

14

FOCUSED ON END MARKETS WITH ATTRACTIVE GROWTH RATES, SUPPORTED BY GLOBAL MEGATRENDS

PRODUCT SPILT KEY PRODUCT CATEGORIES(~ %)

KEY CUSTOMERS

Revenue: €21m

Biocides Personal care Adhesives Rubber

20 10 15

Other

35 20

Mid-term market growth (~%)

Fine chemicals 20%

5 6 4 4

slide-16
SLIDE 16

PRODUCTION FOOTPRINT BY SITE

15

Schönebeck Baar- Ebenhausen Lübeck Wolfenbüttel Ennis/Texas

Revenue (€m) % of total revenue 44,239 15,013 19,417 14,513 19,517 Product split (%)  Agrochemicals  Fine chemicals Utilisation (%) 62 38 63 51 71 Synthesis

    

Formulation

    

Packaging

    

Distribution storage

    

Highlights

State-of-the-art synthesis facility, including pilot plant

Development department

Competence centre for fine chemicals formulation

Small fillings

Competence centre for granulation

Powder and granule fillings

Competence centre for liquid formulation

Liquid fillings

Full range of formulation and filling portfolio

Optimally located to capture southern US market 27 73 53 47 1 99 96 4 95 5

slide-17
SLIDE 17

16

LÜBECK

KEY FACTS

7 573m2 Property size 21 383m2 Production area 121 Employees 63% Capacity utilisation 12 000t Production volume in 2015/16 5 Formulation units: 3 solid, 2 liquid

slide-18
SLIDE 18

17

WOLFENBÜTTEL

KEY FACTS

21 750m2 Property size 10 750m2 Production area 150 Employees 51% Capacity utilisation 32 000t Production volume in 2015/16 6 Formulation units: 2 solid, 4 liquid

slide-19
SLIDE 19

SCHÖNEBECK

18

KEY FACTS

150 000m2 Property size 15 000m2 Production area 256 Employees 62% Capacity utilisation 33 000t Production volume in 2015/16 173m3 Reactor volume (synthesis) 7 Formulation units: 3 solid, 4 liquid 4 Synthesis plants, including 1 pilot plant

slide-20
SLIDE 20

19

BAAR-EBENHAUSSEN

KEY FACTS

38% Capacity utilisation 11 000t Production volume in 2015/16 11 Formulation units: 10 solid, 1 liquid 35 000m2 Property size 126 Employees 21 400m2 Production area

slide-21
SLIDE 21

20

ENNIS, TEXAS

KEY FACTS

169 036m2 Property size 52 405m2 Production area 213 Employees 77 000t Production volume in 2015/16 71% Capacity utilisation 27 870m2 Distribution warehouse 26 Formulation units: 13 solid, 13 liquid

slide-22
SLIDE 22

LEADERSHIP TEAM

21

Dirk Unterstenhӧfer Alfred Ludorf

  • Dr. Karsten Mielke

CEO CFO Senior Manager Business Development

› Years in industry: 22 › Joined Schirm in ’95, re- joined in ’14 › Previously Head of Supply Chain at Cheminova Germany (’13 – ’14) and Commericial Director at StӓhlerTec Germany (’09 – ’12) › Years in industry: 23 › Joined Schirm in ’92, re-joined in ’09 › Previously Controller at Lehnkering (’89 – ’92) and Head of Controlling at Hellweg (’05 –’09) › Years in industry: 19 › Joined Schirm in ’12 › Previously Senior Business Manager at CBW Chemie (’98 – ’11)

slide-23
SLIDE 23

3 FINANCIAL INFORMATION

slide-24
SLIDE 24

PURCHASE CONSIDERATION

23

› Purchase consideration of €110,5m (incl. cash of €6,5m)

Pu Purchase Consideration

Equity 53 544 Loan 49 390 Cash 6 516 Wolfenbuttel Business (CMS)

396

Wolfenbuttel Property

670 110 516

slide-25
SLIDE 25

TRANSACTION CONSIDERATIONS

24

› Imperial to retain certain warehousing and distribution operations on Schӧnebeck and Wolfenbüttel sites

» AECI has entered into a separate agreement to lease warehouse space » AECI retains the option to acquire the warehouse campus in Schönebeck for a maximum amount of €9m » Entered into 25-year lease on Wolfenbüttel property ~ AECI to pay Imperial a pre-payment fee of €3,5m

› Transaction structured as a “locked-box”

» Effective date of 30 June ’17 » Subject to a separate trade working capital adjustment mechanism » Trade working capital pegged at €25m (€21m at 1 July ’17)

slide-26
SLIDE 26

FINANCIAL POSITION AT 30 JUNE ’17

25

› Fixed assets include €25m expansion capex › Other large liabilities comprise mostly pension liabilities

Fixed assets 54 365 Net working capital 18 033 Cash 6 516 Other liabilities 15 125 63 790 Less: Loan - ICL 49 390 Net Assets per SENS 14 400

slide-27
SLIDE 27

RECENT FINANCIAL PERFORMANCE

26

› Plants largely seasonally-utilised, hence strategic capex in ’16 and ’17 › Majority of earnings typically generated January to June

» Objective: create July to December season - fine chemicals and other geographies

› Favourable finished goods storage contracts negotiated with Imperial › Enhanced earnings derived from the rental prepayment of €3,5m

JUNE YE 2015 2016 2017

Revenue 105 113 113 EBITDA 14 14 14 EBITDA% 13,5% 12,8% 12,3%

slide-28
SLIDE 28

CAPITAL EXPENDITURE

27

› Capex in FY16 and FY17 expected to deliver future earnings growth

» Synthesis plant, Schönebeck » Fungicide formulation centre, Schönebeck » Formulation plant, Wolfenbüttel

› Maintenance capex €3m to €4m p.a

2,8 2,2 2,3 6,6 0,6 5,6 12,1 8,1 1,5 1,0 2,2 4,3

13 / 14A 14 / 15A 15 / 16A 16 / 17E

Capex (€m)

Maintenance Schonebeck Expansion Other expansion capex

slide-29
SLIDE 29

ENTERPRISE VALUE

28

› Target Euro IRR for new capital expenditure between 15% and 18% › AECI’s gearing projected to 60% post two acquisitions › Acquisition expected to be earnings accretive to AECI from FY18 › Marginal negative impact on RONA initially

Historic earnings New expansion capital expenditure

TO TOTAL AL Enterpr prise Value EB EBITDA - June ne 20 2017 Multipl ple

100 13,8 7,2 25 125 13,8 9,1

slide-30
SLIDE 30

CONDITIONS PRECEDENT AND TIMING

30

› Approval by German Federal Cartel Office (national competition regulator) › Approval by German Federal Ministry of Economics and Energy › Approval by the SARB › Registration iro transfer of Wolfenbüttel property and municipal authority waiving its statutory rights of pre-emption › Transaction expected to close in 1Q18

slide-31
SLIDE 31

CURRENT OWNERSHIP STRUCTURE

31

Schirm GmbH Schirm USA Wolfenbüttel Contract Manufacturing Business Ennis/Texas Baar- Ebenhausen Schӧnebeck Wolfenbuttel Lübeck

100%

slide-32
SLIDE 32

POST-ACQUISITION OWNERSHIP STRUCTURE

32

Schirm USA Wolfenbüettel Contract Manufacturing Business Ennis/Texas Baar- Ebenhausen Schӧnebeck Wolfenbüettel Lübeck AECI Mauritius

100% 100%

slide-33
SLIDE 33

4 OPPORTUNITIES

slide-34
SLIDE 34

OPPORTUNITIES

34

Step-out in Europe and US › AECI Group already sells key products to European market › Formulation in Germany (vs shipping directly from SA) could deliver efficiencies, savings › Schirm’s knowledge and resources in dealing with complexities of the REACH and European agrochemical regulations may be beneficial Supply to North Africa › Potential efficiencies - supply formulated product via Germany (vs SA) Formulation expertise › Schirm expertise to optimise current formulations › Greater product efficacy, cost advantages › Import replacement for AECI › Beneficial seasonal effects on capacity Relationships with multinationals › Leverage Schirm’s relationships with key multinational customers › Secure favourable distribution terms for Africa Expand current agrochemical portfolio › Existing range of AECI products and services could be expanded into Europe

slide-35
SLIDE 35

5 INCORPORATION INTO AECI

slide-36
SLIDE 36

AECI ORGANOGRAM: POST-TRANSACTION

36

slide-37
SLIDE 37

STRATEGIC PILLARS

37

slide-38
SLIDE 38

THANK YOU